SAN DIEGO - December 12, 2012 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that a compassionate-use clinical program that provides HCV-infected individuals with access to the Hemopurifier� therapy, has been expanded to include individuals who experience a viral breakthrough during standard-of-care drug therapy.

Published: 12 December 2012

Written by Investor Ideas

New York, New York - December 10, 2012 (Investorideas.com newswire, www.techsectorstocks.com) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research for independent investors issues new research and directories for the tech sector including a list of publicly traded mobile security stocks and mobile app stocks.

Mobile Security Stocks

Accenture ( NYSE:ACN) is a global management consulting, technology services and outsourcing company, with approximately 257,000 people serving clients in more than 120 countries.

Published: 10 December 2012

Written by Investor Ideas

SAN DIEGO - December 7, 2012 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce.

At Aethlon Medical, our focus is to create revolutionary medical devices that save lives. In the treatment of Hepatitis C (HCV) infected individuals, we have demonstrated that our Hemopurifier® synergistically combines with drug therapy to accelerate the achievement of undetectable viral load. In cancer, I envision our opportunity to save lives will be driven by the discovery that our Hemopurifier® can addresses a therapeutic target that plays a pivotal role in cancer progression, yet remains beyond the reach of drug therapies. The target? Microvesicles known as exosomes, which are particles secreted by tumors underlying a wide-range of cancers.

Published: 07 December 2012

Written by Investor Ideas

TD to acquire Epoch Investment Partners

Complements TD Asset Management's existing capabilities
Immediately and significantly advances organic growth strategy for TD's North American Wealth business

TD (TD) (TSX and NYSE: TD) and Epoch Holding Corporation (NASDAQ:EPHC ) including its subsidiary Epoch Investment Partners, Inc. today announced that they have signed a definitive agreement under which Epoch will be acquired by TD Bank Group for approximately US$668 million, in an all-cash transaction. Epoch Holding Corporation shareholders will receive US$28.00 in cash per share, representing a premium of approximately 28 per cent to Epoch's closing price on December 5, 2012.

Published: 06 December 2012

Written by Editor

HOUSTON, TEXAS - December 4, 2012 (Investorideas.com energy newswire) EFL Overseas Inc. (OTCBB:EFLO) is pleased to announce the acquisition of additional working interests in the Kotaneelee gas property and the results of independent reserves and resources evaluations (NI-51-101 compliant).

SUMMARY OF RESOURCES

The following reports certain pro forma resource information, based on an independent assessment by AJM dated effective June 30, 2012 using forecast prices and costs (the "EFLO AJM Resource Report"). The EFLO AJM Resource Report was prepared in accordance with definitions, standards and procedures contained in the COGE Handbook and NI 51-101.

Published: 04 December 2012

Written by Investor Ideas

Page 18 of 45

Biotech Stock News; Aethlon Medical (OTCBB: AEMD) Announces Expansion of Compassionate-Use Program To Treat Hepatitis C Virus (HCV)

Tech Stocks Investor Research Update for Mobile Security Stocks and Mobile App Stocks

Biotech Stock News; Aethlon Medical (OTCBB: AEMD) Note: A Medical Device Strategy to Address Metastatic Melanoma

Epoch Holding Corporation ( EPHC )

TD to acquire Epoch Investment Partners

Energy Stock News; EFL Overseas Inc. (OTCBB: EFLO) Reports Acquisition of Additional Interest at Kotaneelee and Reserves and Resources Update